We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Berkshire Hathaway Class A
BRK.A
$1.05T
| $65.7M | 0.2% |
258
-15
| -5% | -$3.75M |
|
102
HEICO Corp
HEI
$46.8B
| $65.2M | 0.2% |
1,771,264
+37,592
| +2% | +$1.38M |
|
103
Philip Morris
PM
$303B
| $64.9M | 0.2% |
552,277
+11,893
| +2% | +$1.38M |
|
|
CTLT
104
DELISTED
CATALENT, INC.
CTLT
| $63.8M | 0.2% |
1,818,548
+43,551
| +2% | +$1.43M |
|
105
Vanguard Dividend Appreciation ETF
VIG
$110B
| $63.8M | 0.2% |
688,401
-633
| -0.1% | -$58.1K |
|
106
MACOM Technology Solutions
MTSI
$21.6B
| $63M | 0.19% |
1,129,414
+18,305
| +2% | +$988K |
|
|
UN
107
DELISTED
Unilever NV New York Registry Shares
UN
| $62.8M | 0.19% |
1,136,979
+443,823
| +64% | +$24M |
|
|
THS
108
DELISTED
Treehouse Foods
THS
| $61.9M | 0.19% |
758,050
+31,413
| +4% | +$2.57M |
|
|
LTRPA
109
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $61.1M | 0.19% |
5,269,287
+77,602
| +1% | +$1.01M |
|
110
AbbVie
ABBV
$448B
| $59.9M | 0.18% |
826,452
-10,384
| -1% | -$698K |
|
111
3M
MMM
$89.1B
| $59.2M | 0.18% |
340,052
+1,490
| +0.4% | +$249K |
|
112
Blackbaud
BLKB
$1.42B
| $58.7M | 0.18% |
684,529
+16,229
| +2% | +$1.33M |
|
113
Coca-Cola
KO
$354B
| $57.4M | 0.18% |
1,280,374
+25,723
| +2% | +$1.14M |
|
114
iShares Russell 2000 ETF
IWM
$81.6B
| $56.9M | 0.17% |
403,806
+47,228
| +13% | +$6.54M |
|
115
Assurant
AIZ
$13.5B
| $56.1M | 0.17% |
541,128
-22,250
| -4% | -$2.22M |
|
116
Murphy USA
MUSA
$11.4B
| $55M | 0.17% |
742,470
+54,918
| +8% | +$3.84M |
|
117
Virtus Investment Partners
VRTS
$1.1B
| $51.9M | 0.16% |
468,184
-12,427
| -3% | -$1.32M |
|
118
DigitalBridge
DBRG
$2.92B
| $51.9M | 0.16% |
921,628
-1,589
| -0.2% | -$86.3K |
|
119
Henry Schein
HSIC
$9.66B
| $51.2M | 0.16% |
713,393
+14,739
| +2% | +$1.03M |
|
120
McGrath RentCorp
MGRC
$2.88B
| $50.6M | 0.15% |
1,461,487
+78,161
| +6% | +$2.67M |
|
121
Woodward
WWD
$24.1B
| $50.2M | 0.15% |
742,474
+20,790
| +3% | +$1.42M |
|
122
Pfizer
PFE
$141B
| $49.6M | 0.15% |
1,556,051
+109,215
| +8% | +$3.44M |
|
123
Arch Capital
ACGL
$34.5B
| $49.3M | 0.15% |
1,586,727
-5,733
| -0.4% | -$182K |
|
124
ESCO Technologies
ESE
$8.44B
| $49.1M | 0.15% |
822,431
+15,077
| +2% | +$879K |
|
125
Primerica
PRI
$9.76B
| $48.9M | 0.15% |
645,679
-37,959
| -6% | -$2.98M |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.